Custom service
Targeting Peptide Discovery and Optimization Services
Discover and optimize targeting peptides specifically for delivery applications
Teams come to this service when they need to discover and optimize targeting peptides specifically for delivery applications. We typically start from delivery-context screening, add internalization-vs-binding ranking where the application demands it, and close the loop with serum-stability filtering so the final delivery-validated targeting peptide behaves consistently across lots.
Design reviews are part of the schedule, not an extra. Sequence, spacer architecture and analytical strategy are signed off before the first synthesis run, which is why the 8–14 weeks timeline holds in practice.
Ligands for nanoparticle and LNP targeting
Motifs validated beyond binding, into uptake
Discovery without a functional delivery readout
In-vivo dosing campaigns without a completed in-vitro validation stage
Delivery programmes are released in two layers: chemical (identity, purity, payload loading) and functional (uptake, knockdown or transfection readout in the agreed cell model). Both layers are documented, because a construct that is chemically perfect but functionally silent is a failure.
Service Highlights
- Delivery-context screening as the default route, with internalization-vs-binding ranking held as a proven fallback
- Serum-stability filtering worked into the design where the application requires it
- Every delivery construct is validated for uptake or knockdown function, not just characterized chemically
- Analytical confirmation of every intermediate before the final release
- Serum-stability and competitive-serum conditions are part of the standard test matrix
- Delivery-validated targeting peptide delivered with a complete conjugation or synthesis certificate
How the work runs
Payload & target review
Payload chemistry, target cell and readout are agreed; Targeting Peptide Discovery and Optimization Services concept routes are drafted.
Construct design
Peptide ligand, linker and presentation are designed; delivery-context screening is selected.
Assembly
The construct is assembled and purified chemically, with payload loading quantified.
Functional validation
Uptake or knockdown is measured in the target cell model, with internalization-vs-binding ranking controls.
Stability & optimization
Serum stability and iteration rounds tune the design to the agreed specification.
Release & hand-off
Delivery-validated targeting peptide plus the validation report is released with a handling SOP.
Specifications & timeline
- Turnaround
- 8–14 weeks
- Typical scale
- mg-scale construct plus validation report
- Chemistry options
- delivery-context screening; internalization-vs-binding ranking; serum-stability filtering
- Deliverable
- Delivery-validated targeting peptide
- QC package
- Chemical QC plus functional uptake/delivery assay data
- Shipping
- Blue ice, aliquoted, with handling SOP
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.